Vivanza Biosciences Confirms Non-Applicability of Related Party Disclosures for Q2 FY27
Vivanza Biosciences Ltd 路 Others (Uncategorized) 路 29 Oct 2026, 10:04 pm
Vivanza Biosciences Confirms Non-Applicability of Related Party Disclosures for Q2 FY27 Vivanza Biosciences announced that submission of Related Party Transactions disclosure under Regulation 23(9) of SEBI LODR Regulations is not applicable for the quarter and half-year ended 30th Sep'26. Under Regulation 15(2), corporate governance provisions are exempt for companies with paid-up equity capital under Rs 10 Cr and net worth under Rs 25 Cr. As of 31st Mar'26, the company's paid-up equity share capital stood at Rs 4.00 Cr, while its net worth was Rs 4.40 Cr, placing it below the mandatory regulatory reporting thresholds.
Original exchange filing (PDF)
More announcements from Vivanza Biosciences Ltd
- Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform .... 路 07 Nov 2026
- Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve unaudited standalone and .... 路 03 Nov 2026
- Non applicability of the statements of Variation and Deviation under regulation 32 of SEBI LODR Regulation, 2015 as Company has not raised any further funds, hence statements of Deviation .... 路 08 Oct 2026
- Voting Result for the 44th Annual General Meeting of the Company 路 12 Sept 2026
- Revised Outcome of the 44th Annual General Meeting of the Vivanza Biosciences Limited 路 12 Sept 2026
- Outcome of the 44th Annual General Meeting of the Members of the Vivanza Biosciences Limited. 路 11 Sept 2026
- Please find enclosed newspaper advertisement w.r.t Notice of 44th AGM of the Company and e-voting information. 路 20 Aug 2026
- Annual Report for the Financial Year 2025-2026 of the Company. 路 19 Aug 2026
